Supraglottic Airway
13
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Supraglottic Airway for Resuscitation in Preemies
Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel
Comparison of Video and Classic Laryngeal Mask Airways
Supraglottic Airway for Resuscitation Trial
The New Third Generation Video Laryngeal Mask Evaluation
I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery
I-gel Plus Supraglottic Airway Device for Surgical Procedures in Prone Position
A Randomised Controlled Trial to Compare Two Supraglottic Airway Devices (Ambu AuraGain vs Air Q-3) in Terms of Performance Characteristics.
AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA
A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients
Comparison of I-gel to the Laryngeal Mask Airway
Clinical Comparison of the Airway Devices
A Comparison of the Ambu AuraGain Versus LMA Supreme in Children